Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers - Enduring "Updated - Winter 2023"

Oncology 101:  A Hematology and Oncology Primer for Advanced Practice Providers - Enduring "Updated Winter - 2023"

The demand for cancer care is expected to grow 40% over the next six years and ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of patients, advanced practice providers (APPs), whose education and training is focused on health promotion, disease prevention, and primary care medical management, have increasingly been sought to filled the shortage. However, many APPs have little background or training in oncology. As a result, oncology practices need to provide new staff with an onboarding program that helps to establish a working baseline level of knowledge of hematology and oncology.

To help APPs prepare for a new career in the specialty of oncology, Horizon CME has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this two-and-a-half-day program with updates and content from the Fall 2022 virtual Oncology 101 course, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team. 

 

LEARNING OBJECTIVES:

Upon completion of this activity, participants should be better able to: 

1. Describe the presentation, evaluation, and treatment of common solid and hematologic malignancies

2. Recognize the presentation, evaluation, and treatment of common benign hematologic disorders 

3. Summarize the role of genetics and molecular testing in cancer care 

4. Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy

5. Identify and appropriately manage common oncologic emergencies

6. Outline the role of survivorship and effectively incorporate it into oncology practice

 

TARGET AUDIENCE:

This program is appropriate for new APPs, nurses, and pharmacists in oncology, clinicians seeking a review, or clinicians considering a career in oncology. 

 

Presented By:  

    

 

Course summary
Available credit: 
  • 14.25 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 14.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 14.25 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 14.25 credit.
  • 6.00 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 6.00 credit.
Course opens: 
02/11/2023
Course expires: 
02/09/2024
Cost:
$125.00
Rating: 
0

(01) Difficult Conversations and End-of-Life Care
» Justin Baker, MD - St. Jude Children's Research Hospital

(02) Immunotherapies
» Joslyn Rudoni, PharmD, BCOP - Cleveland Clinic Taussig Cancer Center

(03) Supportive Care
» Laura J. Zitella, MS, RN, ACNP-BC, AOCN - University of California, San Francisco

(04) Introduction to Malignant Hematology
» Jennie M. Goble, PA-C - Mayo Clinic | ALL, AML, Myelodysplastic syndromes, Myelofibrosis
» Amy Goodrich, CRNP-AC - Johns Hopkins Kimmel Cancer Center | CLL, CML
» Claressa Rosacina, MSN, RN, AGPCNP-BC - Oncology Consultants | Hodgkin lymphoma, Non-Hodgkin Lymphoma

(05) Introduction to Benign Hematology
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Cleveland Clinic | Anemia, ITP, Essential thrombocytosis
» Lauren Imboden, MMS, PA-C - Atrium Health Wake Forest Baptist | Polycythemia, Hemophilia, Coagulopathies (factor V leiden, VTE)

(06) Pain Management in Cancer Care
» Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC - Stanford Health Care

(07) Stem Cell Transplant
» Linda M. Perry, MS, PA-C - Perelman Center for Advanced Medicine

(08) Precision Medicine: The Role of Molecular Testing in Cancer
» Beth Sandy, MSN, CRNP - University of Pennsylvania
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Medical Oncology Cleveland Clinic

(09) Oncologic Emergencies
» Brenda Shelton, DNP, APRN-CNS, CCRN, AOCN, NPD-BC - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

(10) Introduction to Solid Malignancies
» Kristi K. Orbaugh, RN, MSN, RNP, AOCN - Community Hospital Oncology Physicians| Breast Cancer
» Beth Sandy, MSN, CRNP - Abrahamson Cancer Center, University of Pennsylvania | Lung Cancer
» Kelley A. Rone, DNP, RN, AGNP-C - Mayo Clinic | Colorectal Cancer, Liver Cancer
» Victoria Wong, MHS, PA-C - Fox Chase Cancer Center | Prostate and Bladder Cancer
» Jessica Walchonski, PA-C - UCLA Health | Ovarian Cancer
» Grace Cherry, NP - UCLA Health | Melanoma

(11) Chemotherapy Review
» Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - University of Illinois College of Pharmacy

(12) Targeted Therapies
» Jennifer Murphy, PharmD, BCOP - UCD Health, Oncology & Investigational Drug Service

(13) Introduction to Radiology
» Joshua A. Jones, MD, MA - Abramson Cancer Center, University of Pennsylvania

(14) CAR-T Cell Therapy
» Patricia Mangan, RN, MSN, CRNP - University of Pennsylvania

(15) Cancer Survivorship
» Todd Hultman, PhD, ACNP, ACHPN - Presbyterian Healthcare Services

 

Faculty

Justin Baker, MD

Chief, Division of Quality of Life and Palliative Care

St. Jude Children's Research Hospital

Memphis, TN

 

Joslyn Rudoni, PharmD, BCOP

Hematology/Oncology Clinical Pharmacist

Cleveland Clinic Taussig Cancer Center

Cleveland, OH

 

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Associate Clinical Professor

University of California San Francisco

Hematology/Oncology Nurse Practitioner

San Francisco, CA

 

Jennie M. Goble, PA-C

Instructor in Medicine

 Mayo Clinic

 Rochester, MN

 

Amy Goodrich, CRNP-AC

Nurse Practitioner

Johns Hopkins Kimmel Cancer Center

Baltimore, MD

 

Claressa Rosacina, MSN, RN, AGPCNP-BC

Lead Nurse Practitioner/Clinical Support Manager

Oncology Consultants

Houston, TX

 

Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner

Department of Hematology and Medical Oncology Cleveland Clinic

Cleveland, OH

 

Lauren Imboden, MMS, PA-C

Physician Assistant

Atrium Health Wake Forest Baptist

Winston Salem, NC

 

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC

Adult Nurse Practitioner

Stanford Health Care

Redwood City, CA

 

Linda M. Perry, MS, PA-C

Physician Assistant

Perelman Center for Advanced Medicine

Philadelphia, PA

 

Beth Sandy, MSN, CRNP

Nurse Practitioner, Thoracic Medical Oncology

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

 

Brenda Shelton, DNP, APRN-CNS, CCRN, AOCN, NPD-BC

Clinical Nurse Specialist

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, MD

 

Kristi K. Orbaugh, RN, MSN, RNP, AOCN

Adult Nurse Practitioner

Community Hospital Oncology Physicians

Indianapolis, IN

 

Kelley A. Rone, DNP, RN, AGNP-C

Advanced Practice Nurse

Mayo Clinic

Phoenix, AZ

 

Victoria Wong, MHS, PA-C

Physician Assistant

Department of Hematology/Oncology

Fox Chase Cancer Center

Philadelphia, PA

 

Jessica Walchonski, PA-C

Physician Assistant

UCLA Health

Los Angeles, CA

 

Grace Baek, PharmD, BCOP

Clinical Pharmacist, Hematology/Oncology

Fred Hutchinson Cancer Center

Seattle, WA

 

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP

Clinical Oncology Pharmacist

University of Illinois College of Pharmacy

Chicago, IL

 

Jennifer Murphy, PharmD, BCOP

Senior Pharmacist

UCD Health, Oncology, and Investigational Drug Service

San Francisco, CA

 

Joshua A. Jones, MD, MA

Chief, Palliative Service, Radiation Oncology Director, Spine Radiotherapy Program, Associate Professor of Clinical Radiation Oncology

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

 

Patricia Mangan, RN, MSN, CRNP

Nurse Lead, Hematologic Malignancies Program

Abramson Cancer Center,

University of Pennsylvania

Philadelphia, PA

 

Todd Hultman, PhD, ACNP, ACHPN

Palliative Care Director

Presbyterian Healthcare Services

Albuquerque, NM

 

Val R. Adams, PharmD, FCCP, FHOPA, BCOP

Associate Professor, Oncology Specialist

University of Kentucky

Lexington, KY

 

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

 

Faculty, Authors, and Content Developers Disclosures:

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN has no relevant financial relationships to disclose.

Beth Sandy, MSN, CRNP discloses the following relevant financial relationships: Merck, Takeda, Amgen, AstraZeneca, Jazz, and Janssen.

Justin Baker, MD has no relevant financial relationships to disclose.

Joslyn Rudoni, PharmD, BCOP discloses the following relevant financial relationships: Sanofi, Abbvie, BTG medical, Glaxo SmithKline, Seagen, Janssen, CB Partners/Exeter Pharma Consultancy, HMP Group, and AstraZeneca.

Laura Zitella, MS, RN, ACNP-BC, AOCN has no relevant financial relationships to disclose.

Jennie Goble, PA-C has no relevant financial relationships to disclose.

Amy Goodrich, CRNP-AC has no relevant financial relationships to disclose.

Claressa Rosacina, MSN, RN, AGPCNP-BC has no relevant financial relationships to disclose.

Lauren Imboden, MMS, PA-C discloses the following relevant financial relationships: Dova

Pharmaceutical, Sanofi Genzyme, and Genentech.

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC discloses the following relevant financial relationships: Salix and Averitas.

Linda Perry, MS, PA-C discloses the following relevant financial relationships: Incyte, Abbvie, and Kadmon.

Brenda Shelton, DNP, APRN-CNS, CCRN, AOCN, NPD-BC has no relevant financial relationships to disclose.

Kristi Orbaugh, RN, MSN, RNP, AOCN discloses the following relevant financial relationships: BMS, AZ, DSI, Morphosy, Gilead, Lilly, Coherus, and Dova.

Kelley Rone, DNP, RN, AGNP-C has no relevant financial relationships to disclose.

Victoria Wong, MHS, PA-C discloses the following relevant financial relationships: Foundation Medicine.

Jessica Walchonski, PA-C has no relevant financial relationships to disclose.

Grace Baek, PharmD, BCOP has no relevant financial relationships to disclose.

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP discloses the following relevant financial relationships: Genentech and Seagen.

Jennifer Murphy, PharmD, BCOP has no relevant financial relationships to disclose.

Patricia Mangan, RN MSN CRNP discloses the following relevant financial relationships: BMS, Janssen

Takeda, AMGEN Karyopharm GSK, and Novartis.

Joshua Jones, MD, MA has no relevant financial relationships to disclose.

Todd Hultman, PhD., MSN has no relevant financial relationships to disclose.

 

Planners:

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN has no relevant financial relationships to disclose.

Beth Sandy, MSN, CRNP discloses the following relevant financial relationships: Merck, Takeda, Amgen, Astra

Val R. Adams, PharmD, FCCP, FHOPA, BCOP discloses the following relevant financial relationships: Regeneron and BMS.

Available Credit

  • 14.25 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 14.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 14.25 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 14.25 credit.
  • 6.00 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 6.00 credit.

Price

Cost:
$125.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above